Zheng Peng P - OmicsDI

Show results for

Unknown (947)
Proteomics (38)
Transcriptomics (14)
Metabolomics (8)
Genomics (6)

Organisms

Alphavirus (20)
Anemia (20)
Archaea (20)
Bacteria (20)
Betaherpesvirinae (20)
Borrelia (20)
Chlamydomonas reinhardtii (20)
Chlorella vulgaris (20)
Clostridium perfringens (20)
Dengue virus (20)
Eukaryota (20)
Hepatitis B virus (20)
Human alphaherpesvirus 1 (20)
Human betaherpesvirus 5 (20)
Influenza A virus (20)
Influenza C virus (20)
Homo sapiens (19)
Mus musculus (5)
Rattus norvegicus (2)
Beauveria bassiana (1)
Cordyceps militaris (1)
Streptococcus suis 05ZYH33 (1)
Marmota monax (1)
Paeonia ostii (1)
Setaria italica (1)
Gallus gallus (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Middle East respiratory syndrome-related coronavirus (1)
Schizochytrium sp. TIO1101 (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Organisms

Escherichia coli str. K-12 substr. MG1655 (1)

Repository

pride (20)
iProX (18)
biostudies-arrayexpress (14)
MetaboLights (8)
EGA (5)
ENA (1)

Tissue

Cell culture (5)
Epithelial cell (5)
Bone marrow (1)
Bone matrix (1)
Brain (1)
Cell suspension culture (1)
Gastric epithelial cell (1)
Kidney (1)
Leaf (1)
Stem cell (1)
Umbilical vein endothelium (1)
Whole body (1)

Disease

Cervix carcinoma (1)
Diffuse gastric cancer (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (20)
Shotgun proteomics (14)
Mass spectrometry (8)
Affinity purification coupled with mass spectrometry proteomics (3)
Bottom-up proteomics (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Data-dependent acquisition (1)
SRM/MRM (1)

Instrument Platform

Gas Chromatography MS - (3)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - alternating – hilic (1)
6530 Q-TOF LC/MS (Agilent) (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2026 (8)
2021 (8)
2025 (6)
2020 (6)
2022 (5)
2011 (4)
2023 (4)
2014 (3)
2012 (3)
2024 (3)
2017 (3)
2019 (2)
2016 (1)
2015 (1)
2013 (1)
2010 (1)
2018 (1)

CHEBI ID

CHEBI:32816 (4)
CHEBI:17202 (3)
CHEBI:28300 (3)
CHEBI:15741 (3)
CHEBI:16027 (3)
CHEBI:30769 (3)
CHEBI:16068 (2)
CHEBI:75646 (2)
CHEBI:26533 (2)
CHEBI:77237 (2)
CHEBI:86031 (2)
CHEBI:34159 (2)
CHEBI:140768 (2)
CHEBI:45919 (2)
CHEBI:83054 (2)
CHEBI:82753 (2)
CHEBI:83053 (2)
CHEBI:63977 (2)
CHEBI:30813 (2)
CHEBI:82984 (2)
CHEBI:27781 (2)
CHEBI:75168 (2)
CHEBI:28116 (2)
CHEBI:42504 (2)
CHEBI:17626 (2)
CHEBI:70989 (2)
CHEBI:16974 (2)
CHEBI:40410 (2)
CHEBI:28806 (2)
CHEBI:72749 (2)

Metabolite Name

Hexadecanedioic acid mono-L-carnitine ester (2)
Linoleamide (2)
ATP (2)
N6-Acetyl-L-lysine (2)
Carnosine (2)
ADP (2)
Palmitoylcarnitine (2)
Pipecolic acid (2)
Guanine (2)
Proline (2)
Citrate (2)
Creatinine (2)
Cycloartanols and derivatives (1)
Miscellaneous mixed metal/non-metals (1)
N-acylpiperidines (1)
Naphthofurans (1)
Fluorenes (1)
Oxasteroids and derivatives (1)
Galanthamine-type amaryllidaceae alkaloids (1)
Glycosphingolipids (1)
Aristolactams (1)
Oxirane carboxylic acids and derivatives (1)
Bilirubins (1)
Imidazoquinolines (1)
Pyrenes (1)
Phenylpyridines (1)
Organic nitro compounds (1)
Methylpyridines (1)
Heteroaromatic compounds (1)
Phenanthrolines (1)

First Public Date

2014 (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (7)
RNA-seq of coding RNA (6)
RNA-seq of non coding RNA (1)

Release Date

2022 (157)
2025 (150)
2023 (128)
2024 (118)
2021 (72)
2020 (72)
2019 (64)
2018 (45)
2017 (31)
2016 (28)
2015 (23)
2014 (20)
2026 (19)
2011 (10)
2012 (9)
2013 (8)
2010 (3)
2008 (2)
2009 (1)
2006 (1)

Lab affiliation

BGI Research (3)
Bengbu medical college (1)
Center for Proteomics and Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich (1)
College of chemistry and molecular engineering, Peking University (1)
College of chemistry and molecular engineering, Peking University. (1)
Dalian Institute of Chemical Physics, Chinese Academy of Sciences (1)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1)
Faculty of Plant Science and Technology, Huazhong Agricultural University, China (1)
HHubei Academy of Agricultural Sciences, Wuhan, China ubei Academy of Agricultural Sciences, Wuhan, China (1)
Institute of Biology and Medicine, College of Life Science and Healthy, Wuhan University of Science and Technology, Wuhan, China, (1)
Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China (1)
Laboratory of Integrative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou, 510530, China. (1)
Meng Lab, Department of Basic Research, Guangzhou National Laboratory, No.9, XingDaoHuanBei Road, Guangzhou International Bio-island, Haizhu District Guangzhou, Guangdong, 510005, China (1)
NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing 400016, China; (1)
Nanchang University (1)
Peking University (1)
The Affliated Hospital of Guizhou Medical University (1)

Tags

xref:PubMed:19767843 (1)
pathogen (1)
pathogen:bacterium (1)

Previous page
1 / 102
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 102
Next page

Sort by:

Relevance

Page size

Exogenous L-Alanine promotes phagocytosis multidrug-resistant bacterial pathogens (V. parahaemolyticus-infected spleen metabolomics)

Multidrug-resistant bacteria present a major threat to public health. Therefore, new drugs or approaches are urgently needed to manage and mitigate this threat. Here, we screen the molecular candidates that allow the survival of mice upon Vibrio parahaemolyticus infection by integrated p...

2024-09-26 | MTBLS7996 | MetaboLights

Exogenous L-Alanine promotes phagocytosis multidrug-resistant bacterial pathogens (L-Alanine-treated macrophage metabolomics)

2024-09-26 | MTBLS7986 | MetaboLights

Quantitative proteomics analysis reveals novel insights into mechanisms of action of Disulfiram (DSF)

The new uses of the old drugs may reduce cost and shortens the production cycle of research and development, especially that approved by FDA for important clinical conditions. Alcohol abuse Disulfiram (DSF) has been proven safe and shows the promising anti-tumor effect in may preclinical studies. H...

ORGANISM(S): Homo sapiens (Human)

2021-11-27 | PXD024910 | Pride